tiprankstipranks
Solid Biosciences (SLDB)
NASDAQ:SLDB
US Market

Solid Biosciences (SLDB) Financial Statements

505 Followers

Solid Biosciences Financial Overview

Solid Biosciences's market cap is currently ―. The company's EPS TTM is $-3.932; its P/E ratio is -2.18; Solid Biosciences is scheduled to report earnings on August 12, 2024, and the estimated EPS forecast is $-0.65. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue----$ 517.00K
Gross Profit----$ 517.00K
EBIT$ -24.21M$ -22.27M$ -20.98M$ -24.63M$ -31.75M
EBITDA$ -23.88M$ -22.05M$ -21.38M$ -23.98M$ -30.89M
Net Income Common Stockholders$ -24.30M$ -20.34M$ -20.98M$ -24.63M$ -30.07M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 206.07M$ 123.64M$ 142.88M$ 160.19M$ 185.51M
Total Assets$ 248.69M$ 164.94M$ 184.73M$ 205.14M$ 229.59M
Total Debt$ 25.82M$ 26.27M$ 25.04M$ 25.50M$ 25.77M
Net Debt$ -180.25M$ -97.38M$ -117.85M$ -134.69M$ -159.73M
Total Liabilities$ 37.97M$ 38.46M$ 40.37M$ 40.57M$ 45.80M
Stockholders Equity$ 210.68M$ 126.48M$ 144.36M$ 163.73M$ 183.79M
Cash Flow-
Free Cash Flow$ -25.35M$ -20.91M$ -18.28M$ -28.00M$ -28.50M
Operating Cash Flow$ -25.20M$ -20.82M$ -17.90M$ -27.46M$ -28.00M
Investing Cash Flow$ -38.49M$ 45.30M$ -24.64M$ -48.23M$ 37.26M
Financing Cash Flow$ 107.24M$ 505.00K-$ 2.62M-
Currency in USD

Solid Biosciences Earnings and Revenue History

Solid Biosciences Debt to Assets

Solid Biosciences Cash Flow

Solid Biosciences Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis